240 related articles for article (PubMed ID: 30149992)
1. Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.
Shimomura H; Sasahira T; Nakashima C; Shimomura-Kurihara M; Kirita T
Pathology; 2018 Oct; 50(6):642-647. PubMed ID: 30149992
[TBL] [Abstract][Full Text] [Related]
2. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic adenocarcinoma up-regulated factor has oncogenic functions in oral squamous cell carcinoma.
Sasahira T; Kurihara M; Nishiguchi Y; Nakashima C; Kirita T; Kuniyasu H
Histopathology; 2017 Mar; 70(4):539-548. PubMed ID: 27706833
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
5. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
6. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
7. Distinct expression patterns of Toll-like receptor 7 in tumour cells and fibroblast-like cells in oral squamous cell carcinoma.
Ni YH; Ding L; Zhang DY; Hou YY; Huang X; Hu Q
Histopathology; 2015 Nov; 67(5):730-9. PubMed ID: 25828894
[TBL] [Abstract][Full Text] [Related]
8. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD105 shows significant impact in patients of oral cancer and promotes malignancy of cancer cells via CCL20.
Chen CH; Chuang HC; Lin YT; Fang FM; Huang CC; Chen CM; Lu H; Chien CY
Tumour Biol; 2016 Feb; 37(2):1995-2005. PubMed ID: 26334621
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
12. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR
Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194
[TBL] [Abstract][Full Text] [Related]
13. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma.
Jardim JF; Gondak R; Galvis MM; Pinto CAL; Kowalski LP
Histopathology; 2018 May; 72(6):905-913. PubMed ID: 29023924
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
15. Storkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression.
Sasahira T; Nishiguchi Y; Fujiwara R; Kurihara M; Kirita T; Bosserhoff AK; Kuniyasu H
Oncotarget; 2016 May; 7(18):26751-64. PubMed ID: 27050375
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
17. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
18. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
19. p16 expression independent of human papillomavirus is associated with lower stage and longer disease-free survival in oral cavity squamous cell carcinoma.
Satgunaseelan L; Virk SA; Lum T; Gao K; Clark JR; Gupta R
Pathology; 2016 Aug; 48(5):441-8. PubMed ID: 27370365
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of CD57, CD16, and TGF-β expression in oral squamous cell carcinoma.
Taghavi N; Bagheri S; Akbarzadeh A
J Oral Pathol Med; 2016 Jan; 45(1):58-62. PubMed ID: 25808210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
